Guideline aims to recognize the risks, signs, and symptoms of acute HIV infection and to promote HIV testing in individuals presenting with flu-like symptoms or viral syndromes. It provides recommendations for diagnostic testing, treatment, and prevention services to improve patient health and reduc

0 views • 19 slides

Explore the WISE approach to reducing mental health stigma by increasing inclusion, hope, and support. Learn about the types of stigma, stigmatizing ideas and actions, self-stigma, and the ongoing impact of stigma on individuals. Discover how education can play a crucial role in changing societal vi

1 views • 29 slides

This study focuses on developing and implementing a stigma-disrupting curriculum to improve internal medicine residents' attitudes and knowledge regarding patients with substance use disorders. By addressing provider stigma and enhancing preparedness, the aim is to promote positive regard and increa

1 views • 27 slides

This update highlights key points from the PMK No. 23/2022 on combating HIV, AIDS, and STIs. It covers terminologies, goals for eliminating HIV and AIDS by 2030, and strategies such as PrEP and PEP. The guidelines emphasize timely interventions like Post-Exposure Prophylaxis (PEP) and Pre-Exposure P

3 views • 38 slides

In sub-Saharan Africa, a study was conducted among Lake Victoria fishermen in Kenya to assess the effectiveness of a social network-based intervention in improving HIV testing and linkage outcomes. Results showed significantly higher rates of HIV self-testing and linkage to health facilities in the

0 views • 19 slides

Cardiovascular disease is a growing concern in individuals living with HIV, despite advancements in treatment. The REPRIEVE Trial sheds light on the importance of assessing cardiovascular risk and implementing primary prevention measures in this population. Dr. Grinspoon's financial disclosures and

0 views • 35 slides

HIV and AIDS are closely related, with HIV being the virus that leads to AIDS. HIV weakens the immune system by attacking specific white blood cells, while AIDS is the advanced stage of HIV infection. Prevention is crucial as AIDS is a deadly, incurable disease. The transmission of HIV primarily occ

4 views • 14 slides

The REPRIEVE trial focuses on developing a cardiovascular disease prevention strategy for individuals living with HIV. It addresses the increased risk of CVD in this population, even with good viral suppression. The study evaluates the use of pitavastatin, a statin with anti-inflammatory properties,

1 views • 33 slides

Explore how differentiated care is revolutionizing HIV service delivery by shifting the focus to client-centered approaches. Learn about the current challenges in facility-based care, the needs of people living with HIV, best practices from various countries, and innovative ways to provide different

0 views • 8 slides

HIV, a member of the lentivirus subfamily of retroviruses, causes Acquired Immunodeficiency Syndrome (AIDS). HIV-1 and HIV-2 have distinct characteristics, with HIV-1 being global and HIV-2 primarily in West Africa. The virus encodes reverse transcriptase and has an envelope containing glycoproteins

1 views • 31 slides

Communicable Disease Harm Reduction Section collaborated with Simple HealthKit to offer free HIV, syphilis, gonorrhea, chlamydia, and trichomoniasis testing to Wisconsin residents over 18 from August 25, 2023, to October 20, 2023. The aim was to make HIV and STI testing more accessible to those with

0 views • 23 slides

Testing the effectiveness of NAMI's Ending the Silence presentation in combating mental health stigma in schools. Developed in 2007, the program aims to educate students, reach out to communities, and provide support. With widespread implementation since 2014, it focuses on raising awareness, recogn

0 views • 21 slides

The content delves into the complexities of abortion stigma, exploring key definitions, effects of stigma on women's wellbeing, and reflections on its existence across time and location. It addresses why abortion is stigmatized, different levels of stigma, and the impact on individuals, communities,

0 views • 26 slides

This presentation by Dr. Jonathan Morrow highlights the stigma surrounding opioid use disorder treatment, focusing on identifying causes of stigma, using de-stigmatizing language, addressing stigmatizing behaviors, and reducing stigma at an institutional level. It discusses the types and effects of

0 views • 25 slides

Rural communities face challenges related to stigma and substance use disorders, including limited transportation and treatment options. Stigma may be heightened in these areas due to privacy concerns and lack of confidentiality. Initiating evidence-based methods and implementing harm reduction stra

0 views • 14 slides

HIV Post-Exposure Prophylaxis (PEP) is a crucial emergency medical response for individuals exposed to HIV, aiming to prevent infection. It involves a regimen of medications, tests, and counseling services initiated within 72 hours of exposure. HIV transmission occurs through body fluids like blood,

3 views • 27 slides

This content provides an overview of the relationship between TB and HIV, emphasizing the importance of testing HIV patients for latent TB infection and TB patients for HIV. It also outlines the guidelines for managing these co-infections, including diagnostic tests, treatment strategies, and patien

0 views • 17 slides

Despite a decline in stigma associated with HIV, discriminatory attitudes persist globally, impacting access to healthcare and social inclusion. Data reveals variances in attitudes towards people living with HIV across different regions and highlights the need to address discrimination within health

0 views • 29 slides

Self-stigma in the context of HIV involves negative beliefs, thoughts, and behaviors that can lead to shame, guilt, and self-rejection. This article explores the cycle of self-stigma, differences between stigma and discrimination, causes of self-stigma, and its impact on individuals. Addressing inte

0 views • 12 slides

Adventist AIDS International Ministry (AAIM) in Malawi is dedicated to helping those affected by HIV/AIDS through various programs and collaborations. The ministry involves church ministries, collaborations with organizations like ADRA Malawi and the Malawi government, and runs multiple HIV/AIDS pro

4 views • 11 slides

PEPFAR is intensifying efforts on partner notification services for HIV prevention to address the global issue of undiagnosed HIV cases. The initiative aims to improve testing strategies, increase testing volumes, and enhance epidemic control. By reaching HIV testing targets and implementing efficie

0 views • 24 slides

This study led by Dr. Geoffrey Chipungu, an HIV/AIDS Specialist at UNICEF ESARO, explores the rates, trends, and factors associated with HIV viral load suppression (VLS) in children. The research reveals sub-optimal VLS rates in children compared to adults, highlighting the need for improved policie

5 views • 12 slides

HIV, Human Immunodeficiency Virus, attacks the immune system and can progress to AIDS if left untreated. Antiretroviral Therapy (ART) helps control HIV, allowing individuals to live healthy lives. The stages of HIV include Acute Infection, Chronic Infection, and the most severe stage, AIDS. Early de

0 views • 29 slides

This research focuses on stigma associated with identifying at-risk individuals for psychosis. It delves into the impact of societal perceptions on mental health outcomes, presenting findings from studies on public stigma, discrimination, and self-stigma. The study also examines how cultural factors

0 views • 46 slides

PASAN (Prisoners with HIV/AIDS Support Action Network) in Ontario exclusively works with prisoners and ex-prisoners to provide support, education, and advocacy related to HIV/HCV and harm reduction. They aim to ensure healthcare access and continuity of care for prisoners living with HIV/HCV, combat

0 views • 20 slides

This content provides detailed instructions for conducting HIV rapid tests using three different kits: Determine HIV-1/2 Rapid Test, Uni-Gold HIV-1/2 Rapid Test, and Bioline HIV-1/2 Rapid Test. The instructions include steps such as specimen collection, test device preparation, result interpretation

0 views • 5 slides

August 18, 2020, marked the 30th anniversary of the Ryan White CARE Act, a landmark legislation that established the Ryan White HIV/AIDS Program providing care and treatment services to individuals with HIV in the U.S. The Act has been amended several times to extend and revise its purpose, no longe

0 views • 21 slides

Stigma plays a detrimental role in Opioid Use Disorder (OUD) during pregnancy, leading to fear of judgment and hindering individuals from seeking help. This stigma can result in dropping out of treatment programs and societal exclusion. Substance use disorder, including OUD, is highly stigmatized, a

0 views • 24 slides

This training session focuses on the relationship between undernutrition and HIV, discussing how HIV/AIDS affects nutrition among People Living with HIV (PLHIV). It covers the benefits of good nutrition for PLHIV and provides recommendations for Nutrition Assessment, Counselling, and Support (NACS)

1 views • 27 slides

A pilot study in Tanzania aims to improve adherence to antiretroviral therapy (ART) and retention in care among adults living with HIV. The intervention utilizes social norms and priming techniques to address common challenges like poor adherence, retention issues, and stigma associated with clinic

0 views • 24 slides

In response to the HIV/AIDS pandemic, this study focuses on the effectiveness of Pre-Exposure Prophylaxis (PrEP) in reducing HIV transmission among African American men who have sex with men in Orangeburg, SC. The research aims to investigate the impact of PrEP compared to condom use, and the necess

0 views • 6 slides

Maria, a pregnant woman in Malawi, faces the challenge of an unexpected pregnancy and a positive HIV diagnosis. The scenario explores her concerns, midwifery diagnosis, preparation for HIV testing, disclosure of results, and maintaining confidentiality in antenatal care. It also delves into factors

0 views • 10 slides

12.7 million people worldwide inject drugs, with 1.7 million of them living with HIV. The prevalence of HIV among people who inject drugs is 13.1%, highlighting the need for comprehensive service provision including testing, needle programs, opioid therapy, and antiretroviral treatment. The data als

0 views • 4 slides

This presentation highlights the significance of Regenerating Islet-Derived Protein-3 (REG3) and Intestinal Fatty Acid Binding Protein (I-FABP) in microbial translocation, inflammation, and reservoir size in individuals living with HIV. REG3 and I-FABP serve as markers of gut epithelial damage and p

0 views • 7 slides

Stigma is the devaluation of individuals based on specific attributes such as race, HIV status, or gender, leading to discrimination and internalized feelings of shame and worthlessness. HIV-related stigma, discrimination, and internal stigma can have detrimental effects on individuals and communiti

0 views • 12 slides

Structural determinants, including criminalization, stigma, and limited access to services, impact key populations seeking HIV treatment. Despite supportive policies, some groups are still excluded, affecting HIV incidence and mortality rates. Challenges in achieving global HIV treatment goals highl

0 views • 12 slides

Conducted in 2011 and 2013, this study in Jamaica explores the stigma, discrimination, and support experiences of individuals living with HIV. Findings highlight high levels of internalized stigma, experiences of exclusion and harassment, and challenges in disclosure. The study also assesses support

0 views • 38 slides

Global declines in HIV testing and reductions in new initiators, coupled with disruptions in HIV services due to COVID-19, pose challenges for future healthcare. Short-term disturbances could lead to increased HIV-related mortality, emphasizing the need for program responses to mitigate adverse effe

0 views • 10 slides

HIV/AIDS presents complex medical and psychiatric challenges, including HIV-Associated Neurocognitive Disorders (HANDs), which impact patients, families, and caregivers. This presentation by Dr. Mary Ann Adler Cohen provides insights into the prevalence, impact, diagnosis, and treatment of HANDs, em

0 views • 56 slides

Study on long-acting lenacapavir in heavily treatment-experienced HIV individuals after 104 weeks revealed emergence of lenacapavir resistance-associated mutations. Lenacapavir, a potent HIV-1 capsid inhibitor, has shown activity against ARV-resistant strains. The CAPELLA study analyzed lenacapavir

0 views • 11 slides